Literature DB >> 21034245

Immunization with pneumolysin protects against both retinal and global damage caused by Streptococcus pneumoniae endophthalmitis.

Melissa E Sanders1, Erin W Norcross, Quincy C Moore, Jonathan Fratkin, Hilary Thompson, Mary E Marquart.   

Abstract

PURPOSE: To determine whether immunization with pneumolysin (PLY) protects against pneumococcal endophthalmitis.
METHODS: New Zealand white rabbits were immunized with a mutant form of PLY that retains only 1% of its cytolytic activity until serum IgG titers were ≥51,200. For a negative control, rabbits were immunized with phosphate-buffered saline (mock). Each vitreous was injected with 10(2) colony-forming units of a clinical endophthalmitis isolate of Streptococcus pneumoniae. Severity of endophthalmitis was graded by slit lamp examination at 24 and 48 h postinfection (PI). Serial dilutions of vitreous were plated for bacterial colony-forming units quantitation, eyes were extracted for histology, and a whole blood survival assay was performed.
RESULTS: Immunized rabbits had a significantly lower mean slit lamp examination score at 24 and 48 h PI when compared to mock immunized rabbits (P ≤ 0.002). There was not a significant difference in bacterial load in the vitreous at 24 or 48 h PI. Histological sections showed that retinas of mock immunized rabbits appeared to be destroyed, whereas those of PLY immunized rabbits remained largely intact. Damage spread to the aqueous humor, stroma, and conjunctiva of mock immunized rabbits by 48 h PI. Minimal damage was observed in the vitreous of PLY immunized rabbits and did not spread to other parts of the eye. Whole blood from immunized rabbits inhibited the growth of bacteria better than whole blood from mock immunized rabbits.
CONCLUSION: Immunization with PLY helps protect the eye from damage caused by pneumococcal endophthalmitis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21034245      PMCID: PMC2990286          DOI: 10.1089/jop.2010.0077

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  31 in total

1.  Structure and molecular mechanism of a functional form of pneumolysin: a cholesterol-dependent cytolysin from Streptococcus pneumoniae.

Authors:  S J Kelly; M J Jedrzejas
Journal:  J Struct Biol       Date:  2000-10       Impact factor: 2.867

2.  Essential role of domain 4 of pneumolysin from Streptococcus pneumoniae in cytolytic activity as determined by truncated proteins.

Authors:  H Baba; I Kawamura; C Kohda; T Nomura; Y Ito; T Kimoto; I Watanabe; S Ichiyama; M Mitsuyama
Journal:  Biochem Biophys Res Commun       Date:  2001-02-16       Impact factor: 3.575

3.  THP-1 monocytes up-regulate intercellular adhesion molecule 1 in response to pneumolysin from Streptococcus pneumoniae.

Authors:  Justin Thornton; Larry S McDaniel
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

Review 4.  Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions.

Authors:  Michelle C Callegan; Michael Engelbert; David W Parke; Bradley D Jett; Michael S Gilmore
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

5.  American Academy of Pediatrics. Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis.

Authors: 
Journal:  Pediatrics       Date:  2000-08       Impact factor: 7.124

6.  Structural analysis of the protein/lipid complexes associated with pore formation by the bacterial toxin pneumolysin.

Authors:  B B Bonev; R J Gilbert; P W Andrew; O Byron; A Watts
Journal:  J Biol Chem       Date:  2000-11-13       Impact factor: 5.157

7.  Immune responses to novel pneumococcal proteins pneumolysin, PspA, PsaA, and CbpA in adenoidal B cells from children.

Authors:  Qibo Zhang; Sharon Choo; Adam Finn
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

8.  Contribution of pneumolysin and autolysin to the pathogenesis of experimental pneumococcal endophthalmitis.

Authors:  Eugene W M Ng; J Ricardo Costa; Nasrollah Samiy; Kathryn L Ruoff; Edward Connolly; Felecia V Cousins; Donald J D'Amico
Journal:  Retina       Date:  2002-10       Impact factor: 4.256

9.  Endophthalmitis caused by Streptococcus pneumoniae.

Authors:  John J Miller; Ingrid U Scott; Harry W Flynn; William E Smiddy; Richard P Corey; Darlene Miller
Journal:  Am J Ophthalmol       Date:  2004-08       Impact factor: 5.258

10.  Pneumococcal behavior and host responses during bronchopneumonia are affected differently by the cytolytic and complement-activating activities of pneumolysin.

Authors:  Rania Jounblat; Aras Kadioglu; Tim J Mitchell; Peter W Andrew
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

View more
  14 in total

Review 1.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

Review 2.  Targets of immunomodulation in bacterial endophthalmitis.

Authors:  Frederick C Miller; Phillip S Coburn; Mursalin Md Huzzatul; Austin L LaGrow; Erin Livingston; Michelle C Callegan
Journal:  Prog Retin Eye Res       Date:  2019-05-28       Impact factor: 21.198

Review 3.  Modeling intraocular bacterial infections.

Authors:  Roger A Astley; Phillip S Coburn; Salai Madhumathi Parkunan; Michelle C Callegan
Journal:  Prog Retin Eye Res       Date:  2016-05-03       Impact factor: 21.198

4.  Differential bacterial gene expression during experimental pneumococcal endophthalmitis.

Authors:  Justin A Thornton; Nathan A Tullos; Melissa E Sanders; Granger Ridout; Yong-Dong Wang; Sidney D Taylor; Larry S McDaniel; Mary E Marquart
Journal:  Ophthalmic Res       Date:  2015-03-12       Impact factor: 2.892

5.  Essential Role of NLRP3 Inflammasome in Mediating IL-1β Production and the Pathobiology of Staphylococcus aureus Endophthalmitis.

Authors:  Ajay Kumar; Pawan Kumar Singh; Zeeshan Ahmed; Sukhvinder Singh; Ashok Kumar
Journal:  Infect Immun       Date:  2022-04-11       Impact factor: 3.609

Review 6.  The Yin and Yang of Pneumolysin During Pneumococcal Infection.

Authors:  Joana M Pereira; Shuying Xu; John M Leong; Sandra Sousa
Journal:  Front Immunol       Date:  2022-04-22       Impact factor: 8.786

7.  A Novel Biomimetic Nanosponge Protects the Retina from the Enterococcus faecalis Cytolysin.

Authors:  Austin L LaGrow; Phillip S Coburn; Frederick C Miller; Craig Land; Salai Madhumathi Parkunan; Brian T Luk; Weiwei Gao; Liangfang Zhang; Michelle C Callegan
Journal:  mSphere       Date:  2017-11-22       Impact factor: 4.389

Review 8.  Pneumolysin: Pathogenesis and Therapeutic Target.

Authors:  Andrew T Nishimoto; Jason W Rosch; Elaine I Tuomanen
Journal:  Front Microbiol       Date:  2020-07-02       Impact factor: 5.640

Review 9.  The Role of Pneumococcal Virulence Factors in Ocular Infectious Diseases.

Authors:  Angela H Benton; Mary E Marquart
Journal:  Interdiscip Perspect Infect Dis       Date:  2018-11-13

10.  Passive immunization with Pneumovax® 23 and pneumolysin in combination with vancomycin for pneumococcal endophthalmitis.

Authors:  Melissa E Sanders; Sidney Taylor; Nathan Tullos; Erin W Norcross; Quincy C Moore; Hilary Thompson; Lauren B King; Mary E Marquart
Journal:  BMC Ophthalmol       Date:  2013-03-11       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.